Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Ophthalmology Physician in Temecula, CA
NPI: 1306887435Primary Employer
Lobue Laser and Eye Care Medical Center Inc
lobue2020eyes.com
HQ Phone
Get M.D. Thomas's Phone Numberphone_androidMobile
Get M.D. Thomas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1987 - 2026
American Board of Ophthalmology
Ophthalmology
Rush University Medical Center
Residency • Ophthalmology
1983 - 1987
Chicago Medical School at Rosalind Franklin University of Medicine and Science
Medical School
Until 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92083Measurement of field of vision during daylight conditions | 229 | 249 |
| 2 | 92134Diagnostic imaging of retina | 213 | 231 |
| 3 | 92012Eye and medical examination for diagnosis and treatment, established patient | 199 | 374 |
| 4 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 197 | 217 |
| 5 | 92133Diagnostic imaging of optic nerve of eye | 76 | 80 |
Detection and localization of nonmetallic intraocular foreign bodies by magnetic resonance imaging.
Authors: LoBue, T D, Deutsch, T A, Lobick, J, Turner, D A
Journal: Arch Ophthalmol
Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine.
Authors: Richard Giovane, Prashant Tailor, Stephen Lobue
Publication Date: 2018-05-17
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: SURF-201
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 Ophthalmic Suspension dosed BID, DRUG: KPI-121 1% Ophthalmic Suspension dosed BID